Stockreport

Need To Know: The Consensus Just Cut Its AbCellera Biologics Inc. (NASDAQ:ABCL) Estimates For 2024 [Yahoo! Finance]

AbCellera Biologics Inc. - Common Shares  (ABCL) 
PDF their statutory estimates that might leave shareholders a little shell-shocked. Revenue estimates were cut sharply as analysts signalled a weaker outlook - perhaps a sig [Read more]